Health-care conglomerate Johnson & Johnson lost its motion to reverse a $4.7 billion jury verdict awarded to women who blamed ovarian cancer on asbestos in the company's baby powder and other talc products, a Missouri court ruled Wednesday.
Shares of the company slipped 1 percent to $129 a share in afternoon trading. The stock is now down almost 13 percent so far this month, putting it on pace for its worst month since February 2009.
Reuters reported on Friday that J&J knew for decades that asbestos, a carcinogen, was in its Baby Powder.
This story is developing. Please check back for updates.
from Top News & Analysis https://ift.tt/2Coc88v
No comments:
Post a Comment